Common Stock, Shares, Outstanding of DEXCOM INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
DEXCOM INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • DEXCOM INC Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 384,800,000, a 1.5% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

DEXCOM INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 384,800,000 -5,900,000 -1.5% 31 Dec 2025 10-K 12 Feb 2026 2025 FY
Q3 2025 390,000,000 -600,000 -0.15% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 392,200,000 -8,500,000 -2.1% 30 Jun 2025 10-Q 30 Jul 2025 2025 Q2
Q1 2025 392,100,000 -4,000,000 -1% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 390,700,000 +5,300,000 +1.4% 31 Dec 2024 10-K 12 Feb 2026 2025 FY
Q3 2024 390,600,000 +4,200,000 +1.1% 30 Sep 2024 10-Q 24 Oct 2024 2024 Q3
Q2 2024 400,700,000 +14,600,000 +3.8% 30 Jun 2024 10-Q 25 Jul 2024 2024 Q2
Q1 2024 396,100,000 +8,500,000 +2.2% 31 Mar 2024 10-Q 25 Apr 2024 2024 Q1
Q4 2023 385,400,000 -900,000 -0.23% 31 Dec 2023 10-K 18 Feb 2025 2024 FY
Q3 2023 386,400,000 +200,000 +0.05% 30 Sep 2023 10-Q 26 Oct 2023 2023 Q3
Q2 2023 386,100,000 -6,500,000 -1.7% 30 Jun 2023 10-Q 27 Jul 2023 2023 Q2
Q1 2023 387,600,000 +289,500,000 +295% 31 Mar 2023 10-Q 27 Apr 2023 2023 Q1
Q4 2022 386,300,000 -1,700,000 -0.44% 31 Dec 2022 10-K 08 Feb 2024 2023 FY
Q3 2022 386,200,000 +289,300,000 +299% 30 Sep 2022 10-Q 27 Oct 2022 2022 Q3
Q2 2022 392,600,000 +295,900,000 +306% 30 Jun 2022 10-Q 28 Jul 2022 2022 Q2
Q1 2022 98,100,000 +1,400,000 +1.4% 31 Mar 2022 10-Q 28 Apr 2022 2022 Q1
Q4 2021 388,000,000 +291,900,000 +304% 31 Dec 2021 10-K 09 Feb 2023 2022 FY
Q3 2021 96,900,000 +900,000 +0.94% 30 Sep 2021 10-Q 28 Oct 2021 2021 Q3
Q2 2021 96,700,000 +1,300,000 +1.4% 30 Jun 2021 10-Q 29 Jul 2021 2021 Q2
Q1 2021 96,700,000 +4,400,000 +4.8% 31 Mar 2021 10-Q 29 Apr 2021 2021 Q1
Q4 2020 96,100,000 +4,500,000 +4.9% 31 Dec 2020 10-K 14 Feb 2022 2021 FY
Q3 2020 96,000,000 +4,500,000 +4.9% 30 Sep 2020 10-Q 27 Oct 2020 2020 Q3
Q2 2020 95,400,000 +4,200,000 +4.6% 30 Jun 2020 10-Q 28 Jul 2020 2020 Q2
Q1 2020 92,300,000 +1,300,000 +1.4% 31 Mar 2020 10-Q 28 Apr 2020 2020 Q1
Q4 2019 91,600,000 +1,600,000 +1.8% 31 Dec 2019 10-K 11 Feb 2021 2020 FY
Q3 2019 91,500,000 +2,700,000 +3% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 91,200,000 +2,800,000 +3.2% 30 Jun 2019 10-Q 31 Jul 2019 2019 Q2
Q1 2019 91,000,000 +2,900,000 +3.3% 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 90,000,000 +3,000,000 +3.4% 31 Dec 2018 10-K 13 Feb 2020 2019 FY
Q3 2018 88,800,000 +1,900,000 +2.2% 30 Sep 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 88,400,000 +1,900,000 +2.2% 30 Jun 2018 10-Q 01 Aug 2018 2018 Q2
Q1 2018 88,100,000 +1,800,000 +2.1% 31 Mar 2018 10-Q 02 May 2018 2018 Q1
Q4 2017 87,000,000 +2,400,000 +2.8% 31 Dec 2017 10-K 21 Feb 2019 2018 FY
Q3 2017 86,900,000 +2,400,000 +2.8% 30 Sep 2017 10-Q 01 Nov 2017 2017 Q3
Q2 2017 86,500,000 +2,700,000 +3.2% 30 Jun 2017 10-Q 01 Aug 2017 2017 Q2
Q1 2017 86,300,000 +2,900,000 +3.5% 31 Mar 2017 10-Q 02 May 2017 2017 Q1
Q4 2016 84,600,000 +2,900,000 +3.6% 31 Dec 2016 10-K 27 Feb 2018 2017 FY
Q3 2016 84,500,000 +3,200,000 +3.9% 30 Sep 2016 10-Q 01 Nov 2016 2016 Q3
Q2 2016 83,800,000 +3,800,000 +4.8% 30 Jun 2016 10-Q 02 Aug 2016 2016 Q2
Q1 2016 83,400,000 +4,200,000 +5.3% 31 Mar 2016 10-Q 27 Apr 2016 2016 Q1
Q4 2015 81,700,000 +4,400,000 +5.7% 31 Dec 2015 10-K 28 Feb 2017 2016 FY
Q3 2015 81,300,000 +4,900,000 +6.4% 30 Sep 2015 10-Q 04 Nov 2015 2015 Q3
Q2 2015 80,000,000 +4,600,000 +6.1% 30 Jun 2015 10-Q 05 Aug 2015 2015 Q2
Q1 2015 79,200,000 +4,400,000 +5.9% 31 Mar 2015 10-Q 29 Apr 2015 2015 Q1
Q4 2014 77,300,000 +4,800,000 +6.6% 31 Dec 2014 10-K 23 Feb 2016 2015 FY
Q3 2014 76,400,000 +4,700,000 +6.6% 30 Sep 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 75,400,000 +4,200,000 +5.9% 30 Jun 2014 10-Q 06 Aug 2014 2014 Q2
Q1 2014 74,800,000 +4,100,000 +5.8% 31 Mar 2014 10-Q 01 May 2014 2014 Q1
Q4 2013 72,500,000 +3,000,000 +4.3% 31 Dec 2013 10-K 25 Feb 2015 2014 FY
Q3 2013 71,700,000 +2,450,000 +3.5% 30 Sep 2013 10-Q 06 Nov 2013 2013 Q3
Q2 2013 71,200,000 +2,295,000 +3.3% 30 Jun 2013 10-Q 07 Aug 2013 2013 Q2
Q1 2013 70,700,000 +2,150,000 +3.1% 31 Mar 2013 10-Q 01 May 2013 2013 Q1
Q4 2012 69,500,000 +2,000,000 +3% 31 Dec 2012 10-K 20 Feb 2014 2013 FY
Q3 2012 69,250,000 +1,750,000 +2.6% 30 Sep 2012 10-Q 01 Nov 2012 2012 Q3
Q2 2012 68,905,000 +1,574,000 +2.3% 30 Jun 2012 10-Q 06 Aug 2012 2012 Q2
Q1 2012 68,550,000 31 Mar 2012 10-Q 02 May 2012 2012 Q1
Q4 2011 67,500,000 +5,422,000 +8.7% 31 Dec 2011 10-K 21 Feb 2013 2012 FY
Q3 2011 67,500,000 30 Sep 2011 10-Q 02 Nov 2011 2011 Q3
Q2 2011 67,331,000 30 Jun 2011 10-Q 03 Aug 2011 2011 Q2
Q4 2010 62,078,000 31 Dec 2010 10-K 23 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.